GenomOncology’s Precision Oncology Council is designed to give industry experts a place to discuss, collaborate, and learn about the latest tools, workflows, and advancements within precision oncology care. For 2023, this council will be hosted virtually, and we expect your time commitment to be 1-2 hours per quarter, at most. During these meetings, we will dive into a variety of topics, including:
Developments in precision oncology research.
The future of precision oncology care, and what is needed to enhance this care.
The technology required to address the evolving precision oncology needs.
This webpage will be the point of reference for upcoming meetings, polls or questions, and details regarding council members.
Allison Cushman-Vokoun, MD, PhD, University of Nebraska Medical Center
Craig Mackinnon, MD, PhD, University of Alabama at Birmingham
Chad Shaw, PhD
Christopher Lum, MD, Diagnostic Laboratory Services
Erin Ayash, LGC, Personalis
Felix Geist, PhD, Merck KGaA, Darmstadt
Thomas Schneider, MD, Emory Healthcare
Guoli Sun, MD, PhD, Quest Diagnostics – med fusion
Honey V Reddi, PhD, FACMG, Medical College of Wisconsin
Andrew Nelson, MD, PhD, University of Minnesota
Mary Nesline, Labcorp – OmniSeq
Paul DePietro, Labcorp
Nick Renzette, PhD, The Jackson Laboratory
Rama Sompallae, PhD, The University of Iowa
Jeffrey Conroy, Head of Science, OmniSeq; Executive Director, Labcorp
Joel Saltzman, MD, Cleveland Clinic
Margot Schoenborn, JD, Labcorp – OmniSeq
Samir Courdy, City of Hope
Steven Friedman, ARUP Laboratories
Susan Weidner, AmerisourceBergen – IntrinsiQ Specialty Solutions
Susanna V. Ulahannan, MD, MMEd, OU Health Stephenson Cancer Center
Tracey Freitas, PhD, Quest Diagnostics – med fusion
Twinkal Marfatia, PhD, Personalis
Zan Halford, Diagnostic Laboratory Services
Holli Drendel, PhD, FACMG Atrium Health
With over 20 years of software development and leadership experience, Ian leads the technical innovation at GenomOncology. Ian created GenomOncology’s Precision Oncology Platform, and continues to innovate on the platform and GO solution offerings to ensure our precision oncology solutions best serve users.
James has over decade of experience in precision oncology, making him integral in GenomOncology’s understanding of the field of clinical genomics. James works across GenomOncology’s Precision Oncology Platform (POP), ensuring all our precision oncology solutions include the necessary precision oncology data sets in order to inform decision support and streamline patient treatment analysis and research.
Matthew has over 10 years of experience in precision oncology software and data products. Matthew’s expertise is fundamental in the creation and management of the innovation roadmap, guiding initiatives in pathology, bioinformatics, therapy/clinical trial matching, and API design.
